National protocol for model-based selection for proton therapy in head and neck cancer

Johannes A. Langendijk; Frank J.P. Hoebers; Martin A. De Jong; Patricia Doornaert; Chris H.J. Terhaard; Roel J.H.M. Steenbakkers; Olga Hamming-Vrieze; Jeroen B. Van De Kamer; Wilko F.A.R. Verbakel; Fatma Keskin-Cambay; Johannes B. Reitsma; Arjen Van Der Schaaf; Liesbeth J. Boersma; Ewoud Schuit

doi:10.14338/IJPT-20-00089.1

National protocol for model-based selection for proton therapy in head and neck cancer

Johannes A. Langendijk^*, Frank J.P. Hoebers, Martin A. De Jong, Patricia Doornaert, Chris H.J. Terhaard, Roel J.H.M. Steenbakkers, Olga Hamming-Vrieze, Jeroen B. Van De Kamer, Wilko F.A.R. Verbakel, Fatma Keskin-Cambay, Johannes B. Reitsma, Arjen Van Der Schaaf, Liesbeth J. Boersma, Ewoud Schuit

^*Corresponding author for this work

Radiotherapy

Research output: Contribution to journal › Article › Academic › peer-review

54 Citations (Scopus)

123 Downloads (Pure)

Abstract

In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPPHNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

Original language	English
Pages (from-to)	354-365
Number of pages	12
Journal	International Journal of Particle Therapy
Volume	8
Issue number	1
DOIs	https://doi.org/10.14338/IJPT-20-00089.1
Publication status	Published - 25 Jun 2021

Bibliographical note

Publisher Copyright:
© Copyright 2021 The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.14338/IJPT-20-00089.1Licence: CC BY

National Protocol for Model-Based Selection for Proton Therapy in Head and Neck CancerFinal published version, 1.05 MBLicence: CC BY

Cite this

Langendijk, J. A., Hoebers, F. J. P., De Jong, M. A., Doornaert, P., Terhaard, C. H. J., Steenbakkers, R. J. H. M., Hamming-Vrieze, O., Van De Kamer, J. B., Verbakel, W. F. A. R., Keskin-Cambay, F., Reitsma, J. B., Van Der Schaaf, A., Boersma, L. J., & Schuit, E. (2021). National protocol for model-based selection for proton therapy in head and neck cancer. International Journal of Particle Therapy, 8(1), 354-365. https://doi.org/10.14338/IJPT-20-00089.1

@article{077dc8b006f946538a492c2b2a64f590,

title = "National protocol for model-based selection for proton therapy in head and neck cancer",

abstract = "In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPPHNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice. ",

author = "Langendijk, {Johannes A.} and Hoebers, {Frank J.P.} and {De Jong}, {Martin A.} and Patricia Doornaert and Terhaard, {Chris H.J.} and Steenbakkers, {Roel J.H.M.} and Olga Hamming-Vrieze and {Van De Kamer}, {Jeroen B.} and Verbakel, {Wilko F.A.R.} and Fatma Keskin-Cambay and Reitsma, {Johannes B.} and {Van Der Schaaf}, Arjen and Boersma, {Liesbeth J.} and Ewoud Schuit",

year = "2021",

month = jun,

day = "25",

doi = "10.14338/IJPT-20-00089.1",

language = "English",

volume = "8",

pages = "354--365",

journal = "International Journal of Particle Therapy",

issn = "2331-5180",

publisher = "Elsevier",

number = "1",

}

Langendijk, JA, Hoebers, FJP, De Jong, MA, Doornaert, P, Terhaard, CHJ, Steenbakkers, RJHM, Hamming-Vrieze, O, Van De Kamer, JB, Verbakel, WFAR, Keskin-Cambay, F, Reitsma, JB, Van Der Schaaf, A, Boersma, LJ & Schuit, E 2021, 'National protocol for model-based selection for proton therapy in head and neck cancer', International Journal of Particle Therapy, vol. 8, no. 1, pp. 354-365. https://doi.org/10.14338/IJPT-20-00089.1

TY - JOUR

T1 - National protocol for model-based selection for proton therapy in head and neck cancer

AU - Langendijk, Johannes A.

AU - Hoebers, Frank J.P.

AU - De Jong, Martin A.

AU - Doornaert, Patricia

AU - Terhaard, Chris H.J.

AU - Steenbakkers, Roel J.H.M.

AU - Hamming-Vrieze, Olga

AU - Van De Kamer, Jeroen B.

AU - Verbakel, Wilko F.A.R.

AU - Keskin-Cambay, Fatma

AU - Reitsma, Johannes B.

AU - Van Der Schaaf, Arjen

AU - Boersma, Liesbeth J.

AU - Schuit, Ewoud

PY - 2021/6/25

Y1 - 2021/6/25

N2 - In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPPHNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

AB - In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPPHNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=85115788945&partnerID=8YFLogxK

U2 - 10.14338/IJPT-20-00089.1

DO - 10.14338/IJPT-20-00089.1

M3 - Article

C2 - 34285961

AN - SCOPUS:85115788945

SN - 2331-5180

VL - 8

SP - 354

EP - 365

JO - International Journal of Particle Therapy

JF - International Journal of Particle Therapy

IS - 1

ER -

National protocol for model-based selection for proton therapy in head and neck cancer

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this